Pharmacokinetics and Pharmacodynamics of Single Rising Intravenous Doses (0.5 mg-10 mg) and Determination of Absolute Bioavailability of the Dipeptidyl Peptidase-4 Inhibitor Linagliptin (BI 1356) in Healthy Male Subjects.
- Published in:
- Clinical Pharmacokinetics, 2010, v. 49, n. 12, p. 829, doi. 10.2165/11536620-000000000-00000
- Publication type:
- Article